Summary
Adamas Pharmaceuticals
Founded in 2005
Description
Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. With over 30 years of experience, we have expertise in product development and market...
Strengths
- Adamas Pharmaceuticals has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- Since Adamas Pharmaceuticals was founded, the company has grown faster than the industry average
- Web traffic rankings are better than the industry average
Weaknesses
- The number of employees is not growing as fast as the industry average
- Variance of revenue growth is more than the industry average
Annual Revenue
Adamas Pharmaceuticals's annual revenue
$177000
Based on Kona Equity data
-
Revenue per employee
$2425
-
Variance of revenue growth
1713.66
-
Annual revenue growth since founding
$8045
-
Revenue growth rate from first known quarter to current
5862.5%
Employee Count
73 employees
-
Employee growth rate from first known quarter to current
8.2%
Executives
G Score - 5
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
484 K
-
Page views per visitor
2.0
-
Daily time
4:00
-
Bounce Rate
27.3 %
Location
Unlock unlimited leads
Similar Companies
Orphazyme
orphazyme.com- Founded in 2009
- Location: Copenhagen', None
- Annual Revenue: $5.1M
- Employees: 62
- Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients wit...
Visterra , Inc.
visterrainc.com- Founded in 2007
- Location: Waltham, Massachusetts
- Annual Revenue: $18.9M
- Employees: 53
- Visterra is a biologics research and early stage clinical development company developing therapies for patients with immune mediated and other hard to treat diseases. Our proprietary technology platform enables the design and engineering of precision a...
Puma Biotechnology
pumabiotechnology.com- Location: Los Angeles, CA
- Annual Revenue: $200.7M
- Employees: 196
- Puma Biotechnology is a biopharmaceutical company focused on the development and commercialization of innovative products to enhance cancer care. They have licensed the global rights to develop and commercialize several drugs, including neratinib and a...
Evelo Biosciences , Inc.
evelobio.com- Founded in 2014
- Location: Cambridge, MA
- Annual Revenue: $25.8M
- Employees: 122
- Evelo is a clinical-stage biotech with a vision to dramatically improve healthcare. Our work aims to harness SINTAX to modulate the bodys immune system.
Fulcrum Therapeutics, Inc.
fulcrumtx.com- Founded in 2016
- Location: Cambridge, MA
- Annual Revenue: $17.0M
- Employees: 104
- Modulating gene expression to treat the root cause of genetically defined diseases. Learn more about our pipeline and our culture.
Pliant Therapeutics Inc
pliantrx.com- Founded in 2015
- Location: South San Francisco, CA
- Annual Revenue: $6.6M
- Employees: 101
- Pliant is a biotechnology company focused on developing breakthrough treatments for fibrotic diseases. They are dedicated to bringing hope to patients with fibrosis through the discovery and development of novel therapies. Pliant's approach involves ta...
Key Information
- Name: Adamas Pharmaceuticals
- Category: Pharmaceuticals
- Industry: Pharmaceutical company
- SIC: 28; 283
- NAICS: 32; 325
Disclaimer: These numbers are estimates and any other company information
is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona
Equity is in no way affiliated with Adamas Pharmaceuticals.
See similar companies
-
By City Emeryville Small Pharmaceutical company in Emeryville Mid-size Pharmaceutical company in Emeryville Pharmaceuticals in Emeryville Small Pharmaceuticals in Emeryville Mid-size Pharmaceuticals in Emeryville
-
By State CA Small companies in CA Pharmaceuticals in CA Small Pharmaceuticals in CA Mid-size Pharmaceuticals in CA Small Pharmaceutical company in CA Mid-size Pharmaceutical company in CA
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Pharmaceutical company Small Pharmaceutical company Mid-size Pharmaceutical company Pharmaceuticals and Pharmaceutical company
-
Firmographic data G Score of 5 Founded in 2005 SIC: 28 SIC: 283 NAICS: 32 NAICS: 325 #Drug Manufacturing & Research #Pharmaceuticals #Healthcare #Medical Testing & Clinical Laboratories
Frequently Asked Questions
Where is Adamas Pharmaceuticals located?
Adamas Pharmaceuticals's headquarters are located at 1900 Powell St Ste 1000 Emeryville, CA 94608.
What is Adamas Pharmaceuticals's official website?
Adamas Pharmaceuticals's official website is adamaspharma.com
What is Adamas Pharmaceuticals's revenue?
Adamas Pharmaceuticals's annual revenue is $177.0 K.
What is Adamas Pharmaceuticals's SIC code?
Adamas Pharmaceuticals's SIC: 28; 283
What is Adamas Pharmaceuticals's NAICS code?
Adamas Pharmaceuticals's NAICS: 32; 325.
How many employees does Adamas Pharmaceuticals's have?
Adamas Pharmaceuticals has 73 employees
What industry does Adamas Pharmaceuticals belong to?
Adamas Pharmaceuticals is in the industry of Pharmaceuticals.
